This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.
Approval for the zenith alpha thoracic endovascular graft. This device is indicated for the endovascular treatment of patients with isolated lesions of the descending thoracic aorta (not including dissections) having vascular anatomy suitable for endovascular repair, including:1) iliac/femoral anatomy that is suitable for access with the required introduction systems; and2) nonaneurysmal aortic segments (fixation sites) proximal and distal to the thoracic lesion:a) with a length of at least 20 mm; andb) with a diameter measured outer wall to outer wall of no greater than 42 mm and no less than 15 mm.
Device | ZENITH ALPHA THORACIC ENDOVASCULAR GRAFT |
Generic Name | System, Endovascular Graft, Aortic Aneurysm Treatment |
Applicant | COOK MEDICAL INCORPORATED |
Date Received | 2014-08-13 |
Decision Date | 2015-09-15 |
Notice Date | 2015-10-15 |
PMA | P140016 |
Supplement | S |
Product Code | MIH |
Docket Number | 15M-3377 |
Advisory Committee | Cardiovascular |
Expedited Review | No |
Combination Product | No |
Applicant Address | COOK MEDICAL INCORPORATED 750 Daniels Way p.o. Box 489 bloomington, IN 47402-0489 |
Summary: | Summary of Safety and Effectiveness |
Labeling: | Labeling Labeling Part 2 |
Post-Approval Study: | Show Report Schedule and Study Progress |
Approval Order: | Approval Order |
Supplement Number | Date | Supplement Type |
---|---|---|
P140016 | Original Filing | |
S005 | 2022-03-18 | Special (immediate Track) |
S004 | 2021-12-03 | Special (immediate Track) |
S003 | 2021-06-11 | 30-day Notice |
S002 | 2020-10-29 | Normal 180 Day Track No User Fee |
S001 | 2017-06-28 | Special (immediate Track) |